chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report received from a health care professional on 08 October 2010. A 2-year-old female child, with an egg allergy, received on an unknown date a 0.25 milliliter (ml) pediatric dose injection (route and site not reported) of FLUZONE, lot number not provided. Immediately following the vaccination the patient experienced an episode in which she "fell down". The patient was able to walk but she walked "wobbly" down the hallway. The patient was allergic to eggs and has a history of hives when she eats eggs. No further information was available. Follow-up information received from a health care professional on 16 December 2010 reported that the patient's concomitant medication was FLOVENT 44 mcg/act one puff inhaled twice a day (BID). The patient had no illness at the time of vaccination and her birth weight was 5 pounds 1 ounce. The patient has one younger brother. The patient received on 08 October 2010 at 9:00 AM a left arm intramuscular injection of FLUZONE, lot number UT3581AA. The outcome was reported as recovered. Follow-up information was received on 11 February 2011 from a health care professional. The patient, with a history of asthma, was evaluated by a physician and found to be neurologically intact. She was monitored for 30 minutes with eventual resolution of symptoms. Treatments were not required. No further information was provided at the time of the report. Documents held by sender: None.
Received injection at clinic Mon. 08/04/03 yesterday. On 08/05/03 complained of soreness. On 08/06/03 noticed redness and hardness. Brought in to Health Dept to show nurse.
fever, chills, fatigue, jaw and face pain. Took Tylenol and slept, feeling better 12 hours later
Shortly p/recvd vax devel high-pitched crying which lasted until about 3AM on 20SEP91; no other assoc sx observe; no treatment;
Alopecia flair up--had low levels of alopecia since a teenager.  ~3-4 weeks after second and third Moderna shots, hair loss surged dramatically.  Instead of one spot or maybe 2 at a time, experiencing 8-10 spots with continued hair loss after 45 days.  The second shot affects seemed to fade after 90 days.  Third shot impact is ongoing after 75 days.  Dermatologist treating with steroid injections.
Patient experienced pain and soreness at inject site. Patient said he experienced more pain than usual for 3 days.
PATIENT GOT THE FIRST DOSE OF COVID -19 MODERNA VACCINE AND CAME IN TO GET HIS SECOND DOSE OF MODERNA. PATIENT WAS GIVEN COVID - 19 PFIZER VACCINE AS THE SECOND DOSE INSTEAD.
Chills, fever, stomach pain, muscle pain, headache, diarrhea. Took Advil every 4 hours. Effects lasted 24 hours.
This is a spontaneous report from a contactable consumer (patient). A 30-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 30, via an unspecified route of administration, left arm, on Sep 18, 2021, at 13:00, single dose, for COVID-19 immunisation. The patient has no medical history or known allergies. Prior to the vaccination, patient was not diagnosed with COVID-19. Concomitant medications reported as not applicable. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On Sep 18, 2021, at 19:00, patient could not raise her left arm high as it was so sore. She had real bad fatigue, a migraine for about 6 or so hours after she got the shot and off and on headache. The patient was very nauseous for three days and had a build-up of gas after the shot. The patient also had chills since she got it, sore throat and she felt like a cold. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, patient has not tested for COVID-19. No therapeutic measures taken as a result of the events. The outcome of nausea recovered on Sep 21, 2021 (duration of 3 days). The clinical outcome of could not raise her left arm high as it was so sore, real bad fatigue, migraine, off and on headache, build-up of gas, chills since she got it, sore throat and felt like a cold: not recovered at the time of report. The batch/lot numbers for, BNT162B2, not provided and will be requested during follow-up.
Client vaccinated too early as per EUA guidance for Moderna COVID-19 vaccination time/dose intervals.  informed by dept that the client had a previous dose of Moderna on 2/2/2021 and presented to our program for a follow up dose on 2/25/21, 5 days earlier than the EUA states.  Client did not disclose this information to program personnel during his visit for the 2nd dose Moderna.  No adverse events were witnessed at that time, none have been reported to this program.
Abdominal swelling and pain around the belly and back. Pain Similar to after effects of passing kidney stone.  Loss of appetite due to this. Abdominal swelling subsided after 48 hours.
On 2-2-2013 patient felt cold and blue and not responding. No fever. Was on ventilator for 1 day in Peds ICU for respiratory distress. Received albuterol and antibiotic.
Pt received shots 7/11/11, mom noticed area was red, swollen, 7/12/11, hot to touch area measured 1.5in x 1.5in. Pt was told to ice area and use BENADRYL q 6 hours. 7/13/11 pt returned area was larger 3 1/2 in x 2 1/2in. Red, swollen, hot to touch. Painful. Pt given TOPICORT to apply BID, continue BENADRYL q 6 hours & apply ice. DTaP shot was given in affected area.
Received vaccine on 5/2/17. Began breakout on 5/9/17 of papular rash.
patient had fever of 2 days between 100.9-101.4. tylenol was given with some relief but temp went back up again. patient had muscle aches and joint pains. pain at the injection site. tylenol was given with some relief.  patient had severe fatigue for 2 days.
12 year patient was administered a pediatric dose Pfizer.  After mistake was noticed, situation was explained to mother. Reviewed data, ok to give correct dose today. Mother informed and agreeable to plan.
he developed swollen arm on same side as vaccination within 24hours.  As that faded, he developed hives.  By 5/8/21 he had developed a significant, bilateral hand desquamating rash which peeled the skin off both hands and was resistant to topical steroid treatment.  Within a month, his fingers were swelling in the mornings, and he developed additional rashes underneath both arms/arm pits that were eventually diagnosed as inverse psoriasis.  He has responded to high dose steroids, but his skin flares when the steroids are tapered.  He was worked up for herpetic whitlow (negative labs), Lyme (negative labs), candida (did not respond to high dose diflucon).  He never had a single rheumatologic or derm symptom prior to the vaccination  He appears to have developed inverse psoriasis rashes of hands and arm pits, and my also have developed ensenthopathy since the COVID vaccination Moderna
Client was given Moderna as her first dose of the COVID-19 vaccination, but was only eligible for Pfizer.  Error found on form.   Parent  notified of error.  Medical Director was contacted, notified of error.  Per Dr., client may get Pfizer for 2nd dose.  Parent made aware of Dr. recommendation.
Rec'd vaccines 9/24/07. Slept all day. 9/25/07 Fussy, cried all day. Vomited all night. 9/26/07 Vomited in A.M. - rash on chest, abdomen.
Invalid dose, vaccine exposed to a temperature excursion. Attempted to notify patient by phone without success. Mailed a letter to notify patient that the dose received is invalid and needs to be repeated. Plan to follow up in 1 week if no response from letter.
52 y.o. with myalgia, arthralgia, and headaches started about 1 hour after receiving Moderna coronavirus vaccine #1 of 2 on 5/6/2021.  Specifically, left deltoid pain limits ability to left objects.
Patient received TD 6/30/09 for health maint. update. She called clinic 8/25/09 stating her arm has been painful since getting the vaccine. She was examined by Dr 11/11/09 - xrays showed minimal degenerative changes left shoulder. Examined by Dr 12/3/09 - advised physical therapy, warm packs and anti-inflammatories. Pt contacted Dr 1/5/2010. Evaluated by neurologist 2/8/10 and p.t. eval 3/10/10.
7 months between 1 and 2 dose; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in November 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 29-JUN-2022 Reporter's Comments: This case reported by the patient via interactive digital media. The patient received 1st Shingrix vaccine in November 2021. It had been over 7 months before the day of reporting.  The patient asked if he/she could still get second vaccine. Additional Supportive Information: The patient received 1st dose of shingrix over 7 months before and till the time reporting the patient did not received 2nd dose which led to incomplete course of vaccination.
Pt inadvertly received TDAP instead of Td.  No adverse events noted at time of vaccination.
Patient received COVID-19 Booster shot on 02/10/2022 LOT #33036BD. Upon returning to the clinic on 02/12/2022,  The patient was lethargic and not feeling well. He had a hypotensive episode and a hypoglycemic episode as well. Vitals were baseline during the assessment for this patient. He had no complaints post treatment. He returned to the clinic 02/15/2022 and was back at baseline without complaint.
Pain on the lymph nodes/lymph nodes hurting; Hurting really bad; Pleurisy before getting the vaccine/after getting the vaccine it got really bad; Pleurisy before getting the vaccine/after getting the vaccine it got really bad; This is a spontaneous report from a contactable consumer (patient). An 82-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9261; Expiration date: 31May2021) on 21Jan2021 (07:00) at a single dose on the left arm, with route of administration unspecified, for COVID-19 immunization at the clinic (not a military facility). Medical history included being a diabetic from 2005 and ongoing (was not on insulin, only on pills); ongoing chronic obstructive pulmonary disease (COPD) in her 50's (also reported as "it has been a while"), and was not on oxygen; ongoing anxiety attack; had a problem with her left lymph nodes in her breast; and had pleurisy that was not really that bad (taking paracetamol (TYLENOL)). Concomitant medication included ongoing metformin for being diabetic. In Jan2021, the patient had developed pain on the lymph nodes after receiving the vaccination; and the patient was hurting really bad. The patient was previously diagnosed with pleurisy (prior to the vaccination), and it was described as "bad enough for her to take Tylenol" and it was just distracting before. After getting the vaccination, in Jan2021, the patient's pleurisy got really bad, and stated that the vaccine might have attacked her lymph nodes especially the lymph nodes on her left breast, left chest, under arm and back, and that she thought the vaccine had made the pleurisy worse. The patient's condition was so bad that she had to go back to the doctor; events resulted into physician office visit. The patient was informed to take two ibuprofen 200 mg a day as treatment for the reported events. The patient had a chest-ray in Jan2021 after the doctor had diagnosed her with pleurisy (results were not provided). The outcome of the events was not recovered for 'pleurisy that got really bad'; and was unknown for 'pain on the lymph nodes' and 'hurting really bad'.
Patient was given vaccine.  She then stood with mother and left booth.  She then returned with mother to sit down and passed out before getting to the chair.  Patient was helped up to chair by mother and pharmacist.  She was given an ice pack and remained sitting for about 30 minutes.  Patient felt better and was walked to car with mother and pharmacist.  Patient admitted to not eating and to being very anxious about getting vaccine.  Mother was taing her to eat and home to rest.
My left upper arm started to get really sore almost like a bruise. It was itching. It aches most of the time and I am unable to reach behind my back or to stretch to the side of me. I am unable to sleep on left side.  As of this time, I am applying heat and taking Advil. It just hurts for no reason and I still have soreness where the shot was given.
Patient received a Hep A (dose#2) vaccine on 10/01/18. At 12 midnight 10/02/18 his parents awakened to him 'having convulsions". This involved jerking of the upper extremities and leg movement. He also had drowsiness x 20 min. Through the next day he was fatigued. There was headache, which resolved by 10/02/18.
Patient presented with significant redness and swelling at the injection site (about 5 inches in diameter) He complained of tenderness. Outcome unknown.
No additional AE; received a Shingrix vaccine by mistake instead on her second "varicella vaccine"/uncertainty of whether the patient received VARIVAX as her first dose of "varicella vaccine"; This spontaneous report was received from a nurse referring to a 34-year-old female patient. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.      On 28-OCT-2022, the patient was vaccinated by mistake with varicella zoster vaccine rge (cho)(SHINGRIX) (dose, lot number, expiration date and route of administration not reported) for prophylaxis, instead of a second dose of varicella virus vaccine live (oka/merck)(VARIVAX) (wrong product administered). No adverse event was reported.
cold feeling in chest; About 35 minutes post 2nd vaccine, I had a severe panic attack; Flushing feeling; shortness of breath; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient (not pregnant, age at vaccination: 35-year-old) received the second dose of bnt162b2 (BNT162B2, lot EW0161), via an unspecified route of administration in the right arm, on 15Apr2021 as SINGLE DOSE for Covid-19 immunisation. The patient's medical history was not reported. She had her first dose of bnt162b2 (lot EN6204) on 18Mar2021, administered in the left arm. The patient previously took aspirin (acetylsalicylic acid) and experienced drug allergy. Concomitant medications included atenolol, hctz, hydrocodone, cyclobenzaprine hydrochloride (FLEXERIL) and gabapentin; taken for an unspecified indication, start and stop date were not reported. On 15Apr2021 19:45, she had panic attack, flushing feeling, shortness of breath and cold feeling in chest. These did not occur with the 1st dose of vaccine. As treatment, she was given with 3mg Ativan PO (oral). The outcome of events was recovering.  Information on the lot number was already obtained.
Fever up to 102. Strange sensations of "feathers and ice" of muscles. Vomiting.
Severe headache for 48 hours Mild headache for one week Severe fatigue for 48 hours Fatigue for one week Loss of appetite for 24 hours Night sweats and low grade fever for 72 hours Loss of concentration for one week
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date those patients were vaccinated with VARIVAX (Merck) (dose, units, route of administration, anatomical location, lot number were not reported) that was exposed to temperatures above the recommended storage range. The reporter was not aware of any adverse experiences. Additional information has been requested.
3 patients received booster doses from an expired vial (lot #001C21A & a manufacturer expiration date of 13Dec2021) of the Moderna Covid-19 Vaccine today 15Dec2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (3 patients received booster doses from an expired vial (lot #001C21A & a manufacturer expiration date of 13Dec2021) of the Moderna Covid-19 Vaccine today 15Dec2021) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (3 patients received booster doses from an expired vial (lot #001C21A & a manufacturer expiration date of 13Dec2021) of the Moderna Covid-19 Vaccine today 15Dec2021). On 15-Dec-2021, EXPIRED PRODUCT ADMINISTERED (3 patients received booster doses from an expired vial (lot #001C21A & a manufacturer expiration date of 13Dec2021) of the Moderna Covid-19 Vaccine today 15Dec2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment information was not reported. Expiry date of vaccine was 13 Dec 2021.   This case was linked to MOD-2021-414451, MOD-2021-414474 (Patient Link).
A physician reported that a 35 month old male received an injection of Prevnar on 5/10/00. Three days later, he developed an allergic rash. He was treated with diphenhydramine and recovered within 3 days. This is 1 of 2 patients form this facility who experienced this event following receipt of Prevnar.
DERMATOLOGIC- ERYTHEMA AT INJ SITE, SWELLING AT INJ SITE; GASTRO-DECREASED APPETITE; PSYCHIATRIC-IRRITABILITY.
Information has been received from a registered nurse referring to unspecified patients of unknown age and gender. The patients' pertinent medical history and drug reactions/allergies were not reported. On unknown dates the patients were vaccinated with doses of PRIQUAD (Merck) (lot # L009209 with expiration date 17-SEP-2016; dose, route and dose number were not reported), which were exposed to temperatures outside of the recommended range. No adverse effects were reported. This is one of several cases from the same reporter. Additional information has been requested.
This spontaneous report as received from a consumer refers to her 22 years old male son with no pertinent medical history and no drug reactions/ allergies. The patient was intramuscularly vaccinated with the first, second and third dose of 0.5 ml GARDASIL on 12-JUN-2010, 20-AUG-2010 and 07-JAN-2011. No other co-suspects were reported. Concomitant medications included prednisone, sulfasalazine and ORENCIA. In February 2011 the patient experiencing joint pain. The pain started in his elbow, which filled with fluid. He was now immunocompromised. The pain had spread to all his joints and was being treated now as though he had rheumatoid arthritis, even though he did not meet all the criteria for that diagnosis. Some days he can hardly walk. His left hip was now damaged. He had failed treatments with ENBREL and REMICADE already. The patient had sought medical attention via seen health care professional. X-Rays and MRI were performed with no results reported. The outcome of joint pain started in his elbow, which filled with fluid, immunocompromised, his left hip is now damaged, rheumatoid arthritis, hardly walk and joint pain started in his elbow and spread to all his joints was reported as not recovered/not resolved. Additional information is not expected.
pt  said he said his arm is sore, he felt shaky, cold and had a slight temperature the night after taking the vax.  The next morning he had a seizure that lasted a few minutes.  Pts mother contacted his neurologist.  Pt was told the seizure could have possibly been related to him taking the vax.  He will FU w/ him on his next scheduled appt in June 2021.  His symptoms feels better today except his tongue is still sore from biting it during the seizure.
Narrative: 70 yo M received flu shot and covid booster on same day. Reports feeling fatigue, lightheaded, and feverish. Symptoms resolved on own, Remained afebrile since presenting to hospital. Given reported leg weakness prior to  vaccination, unlikely Guiilen barre. Patient reported resolution of fatigue and lightheadedness 24 hours later and feels capable of ambulating with walker.
Given immunizations 2 days ago. Yesterday (9/11) evening complained arm hurt. Left upper arm min. swelling with 5 x 7.5cm redness, no temp.
Acute cerebral venous sinus thrombosis of multiple sites.  Developed symptoms shortly after receiving vaccine.  Diagnosed at hospital on 5/29/21 and transferred to another hospital for tertiary care.  Treated medically with anticoagulants and did well.  Discharged on 6/1/21.
Extreme arm itching 6 days after 1st dose; Red from injection to elbow 6 days after 1st dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Extreme arm itching 6 days after 1st dose) and VACCINATION SITE ERYTHEMA (Red from injection to elbow 6 days after 1st dose) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011m20a) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PRURITUS (Extreme arm itching 6 days after 1st dose) and VACCINATION SITE ERYTHEMA (Red from injection to elbow 6 days after 1st dose). At the time of the report, PRURITUS (Extreme arm itching 6 days after 1st dose) and VACCINATION SITE ERYTHEMA (Red from injection to elbow 6 days after 1st dose) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include hypertension meds and vitamins. Treatment included Alcohol and Gold Band   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow-up information received on 07 MAY 2021 contains No new information
The patient was held in the office 15-30 mins post immunization. He was at his baseline when he left. His mother called at 2:35 to report that he passed out on his way home and had a minor vehicle accident- crashed into a parked car.
nausea & flu like stomachache;felt like throwing up for hours 18-48 p/vax
This spontaneous report as received from a pharmacist refers to a 58 year old female patient. The patient's pertinent medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. On 30-MAR-2016 the patient was vaccinated with first dose of ZOSTAVAX 19400 PFU (0.65 ml, lot # L039096 with an expiry date of 08-JAN-2017), subcutaneous. No concomitant medications were reported. On an unknown date in 2016 the patient experienced swelling at the injection site the size of a baseball which was red and hot (injection site swelling, injection site warmth and injection site redness). The patient sought medical attention by making a call to the pharmacists. The outcome of the events was reported as not recovered/not resolved. The reporter did not provided the causality assessment between the events and the suspect therapy. There was no product quality complaint involved. Additional information has been requested.